Mayo Foundation for Medical Education and Research
发明人:
MARKOVIC, Svetomir N.,NEVALA, Wendy K.
申请号：
EP17750912
公开号：
EP3413874A4
申请日:
2017.02.10
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
Disclosed herein are improved compositions and methods involved in treating hematologic cancers, i.e., cancers that begin in blood-forming tissue, such as the bone marrow, or in the cells of the immune system. The compositions comprise complexes containing albumin-containing nanoparticles (e.g., ABRAXANE® nanoparticles) and antibodies. The compositions are used to effect hematologic cancer cell death.
